Towards Healthcare
Computer-Aided Drug Design (CADD) Market Trends 2025

Computer-Aided Drug Design (CADD) Market Sees $130M UChicago Collaboration

The computer-aided drug design (CADD) market is primarily driven by the increasing need for developing new drugs. The growing new drug discovery research and technological advancements drive the market. North America led the global market owing to the presence of key players and increasing investments.

Content

  • Insight Code: 5819
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The global CADD market is set to surge, with strong growth and high revenue expected from 2025 to 2034.

North America is leading the computer-aided drug design (CADD) market due to the presence of key players, the rising adoption of advanced technologies, and increasing investments.

The computer-aided drug design (CADD) market includes six segments including by type, by technology, by application, by end-user, by deployment mode, and by region.

Some key players include Schrödinger, Inc., BIOVIA (Dassault Systèmes), Molsoft LLC, and BioSolveIT GmbH.

Key trends include the growing new drug discovery research, technological advancements, and favorable government support.

The main principle of CADD involves the use of computer algorithms on chemical and biological data to simulate and predict how a drug molecule will interact with its target.

The primary objectives of CADD include enhancing bioactive chemicals, providing therapeutic alternatives, and comprehending molecularly based biological activities.

World Health Organization, Food and Drug Administration, National Medical Products Administration, Government of Canada, Business France
Any Questions